Interesting facts
Interesting Facts about 4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene
This compound, marked by its complex structure and unique substituents, is a fascinating example of modern organic chemistry. Compounds like this one often exhibit unique properties and biological activities, making them significant in fields such as medicinal chemistry and drug development. Here are some intriguing aspects of this compound:
- Diverse Structural Features: The presence of both bromine and chlorine atoms introduces halogenation, which can significantly influence chemical reactivity and stability. This can lead to enhanced interactions in biological systems.
- Multi-ring System: The name indicates a tricyclic structure, which often contributes to unusual electrochemical properties, allowing for potential applications in materials science.
- Importance in Drug Design: Compounds with such specific molecular configurations are often synthesized as part of pharmacological research, aiming to identify new treatments for various diseases.
- Tetrazole Incorporation: The presence of tetrazole rings typically enhances a compound's bioactivity and can improve solubility or stability, essential for effective drug formulation.
- Chirality and Stereochemistry: If the compound exhibits chirality, it may have different biological activities based on its stereoisomers, adding another layer of complexity to its synthesis and application.
In the words of the renowned chemist, Marie Curie, “Nothing in life is to be feared, it is only to be understood.” Understanding complex compounds like this one paves the way for breakthroughs in various scientific domains. Continued research into such intricate molecules not only enriches our understanding of chemistry but also unleashes new potential in therapeutic interventions.
Synonyms
brotizolam
Lendormin
Lendorm
57801-81-7
Mederantil
Sintonal
WE 941
Brotizolamum
Nimbisan
Brotizolamum [INN-Latin]
5XZM1R3DKF
EINECS 260-964-5
Lendormin (TN)
WE-941
BRN 0839277
2-bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
DTXSID0022692
WE-941-BS
Brotizolam [USAN:INN:BAN:JAN]
BROTIZOLAM [MI]
BROTIZOLAM [INN]
BROTIZOLAM [JAN]
2-Bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine
BROTIZOLAM [USAN]
BROTIZOLAM [MART.]
BROTIZOLAM [WHO-DD]
CHEMBL32479
DTXCID902692
BROTIZOLAM [EP MONOGRAPH]
2-Bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno(3,2-f)-s-triazolo(4,3-a)(1,4)diazepine
6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 2-bromo-4-(2-chlorophenyl)-9-methyl-
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 2-bromo-4-(2-chlorophenyl)-9-methyl-
8-Bromo-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo(3,4c)thieno(2,3e)-1,4-diazepine
NCGC00183872-01
Brotizolamum (INN-Latin)
BROTIZOLAM (MART.)
2-Bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine
C15H10BrClN4S
BROTIZOLAM (EP MONOGRAPH)
Lindormin
Brotizolam (1.0mg/ml in Acetonitrile)
2-BROMO-4-(2-CHLOROPHENYL)-9-METHYL-6H-THIENO(3,2-F)-S-TRIAZOLO(4,3-A)(1,4)DIAZEPINE
8-BROMO-6-(O-CHLOROPHENYL)-1-METHYL-4H-S-TRIAZOLO(3,4-C)THIENO(2,3-E)-1,4-DIAZEPINE
UNII-5XZM1R3DKF
Lendormine
Indormyl
Ladormin
2-Bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin
2-Bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin
4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetraazatricyclo(8.3.0.02,?)trideca-2(6),4,7,10,12-pentaene
4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetraazatricyclo(8.3.0.02,6)trideca-2(6),4,7,10,12-pentaene
4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.02,?]trideca-2(6),4,7,10,12-pentaene
4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene
Brotizolam; 2-Bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno-[3,2-f][1,2,4]-triazolo[4,3-a][1,4]diazepine
SCHEMBL44067
Brotizolam (JP18/USAN/INN)
CHEBI:31308
WE 941-BS
N05CD09
Brotizolam 0.1 mg/ml in Methanol
Brotizolam 1.0 mg/ml in Methanol
Tox21_113601
BDBM50011875
AKOS016014338
DB09017
4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene
CAS-57801-81-7
DB-053108
NS00006212
D01744
L000775
Q850074
2-Bromo-4-(2-chloro-phenyl)-9-methyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulene
2-Bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a]-[1,4]diazepine
260-964-5
6H-Thieno(3,2-F)(1,2,4)Triazolo(4,3-A)(1,4)Diazepine,2-Bromo-4-(2-Chlorophenyl)-9-Methyl-
Solubility of 4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene (C10H12ClNO2)
The solubility of the compound 4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene can be influenced by several factors, including its molecular structure, polarity, and the presence of functional groups.
In summary, predicting the precise solubility of this compound requires consideration of its balance between polar and non-polar characteristics. It would generally exhibit:
Understanding these aspects is crucial for applications related to this compound, particularly in areas like pharmacology and materials science.